Cetintas et al. (2014) indicated that BM-MSCs inhibited significantly the proliferation of ALL cell line CCRF-CEM via changes in the gene and protein expression levels of BAX, caspase 9, and P53 (27). The gene discussed is CASP9; the disease is acute lymphoblastic leukemia.